Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System: Hearing Before the Special Committee on Aging, U.S. Senate, One Hundred Fourteenth Congress, Second Session [2016]

MLA

Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System: Hearing Before the Special Committee on Aging, U.S. Senate, One Hundred Fourteenth Congress, Second Session [2016]. U.S. Government Publishing Office

APA

(2016). Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System: Hearing Before the Special Committee on Aging, U.S. Senate, One Hundred Fourteenth Congress, Second Session [2016]. U.S. Government Publishing Office.

Chicago

Valeant Pharmaceuticals' Business Model: The Repercussions for Patients and the Health Care System: Hearing Before the Special Committee on Aging, U.S. Senate, One Hundred Fourteenth Congress, Second Session [2016]. U.S. Government Publishing Office